Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000244695 | SCV000304529 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Athena Diagnostics Inc | RCV000710865 | SCV000841172 | benign | not provided | 2017-11-13 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000244695 | SCV000967074 | benign | not specified | 2016-03-21 | criteria provided, single submitter | clinical testing | p.Lys664Asn in exon 26 of COL4A5: This variant is not expected to have clinical significance because it has been identified in 1.47% (127/8628) of South Asian c hromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute .org; dbSNP rs34077552). |
Invitae | RCV000710865 | SCV001020605 | benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000021348 | SCV001875866 | benign | X-linked Alport syndrome | 2021-07-30 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000710865 | SCV001915163 | benign | not provided | 2019-01-15 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 17396119, 11462238, 8940267, 17660027) |
Genome Diagnostics Laboratory, |
RCV002293988 | SCV002587569 | benign | Atypical hemolytic-uremic syndrome | 2022-10-05 | criteria provided, single submitter | clinical testing |